OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanodelivery of cGAS-STING activators for tumor immunotherapy
Jianfeng Guo, Leaf Huang
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 11, pp. 957-972
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity
Xiaona Chen, Fanchao Meng, Yiting Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 75

Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39

Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives
Cuiqing Huang, Ni Shao, Yanyu Huang, et al.
Materials Today Bio (2023) Vol. 23, pp. 100839-100839
Open Access | Times Cited: 36

Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors
Jiaxin Zhang, Siyuan Wang, D D Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23

Agonists and Inhibitors of the cGAS-STING Pathway
Xiaoxuan Yu, Linxiang Cai, Jingyue Yao, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3121-3121
Open Access | Times Cited: 14

Anti-stromal nanotherapeutics for hepatocellular carcinoma
Zhuo Yu, Leaf Huang, Jianfeng Guo
Journal of Controlled Release (2024) Vol. 367, pp. 500-514
Closed Access | Times Cited: 10

Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway
Yi Yang, Jialong Qi, Jialin Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216765-216765
Closed Access | Times Cited: 10

Peroxidase‐Like Nanozyme Activates the cGAS‐STING Pathway via ROS‐Induced mtDNA Release for Cancer Immunotherapy
Xueqin Zhu, Xiaoxi Wang, Zimai Liu, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 10

Delivery of STING agonists for cancer immunotherapy
Jianping Wang, Fanfei Meng, Yoon Yeo
Current Opinion in Biotechnology (2024) Vol. 87, pp. 103105-103105
Closed Access | Times Cited: 9

Spiky metal-organic framework nanosystem for enhanced cuproptosis-mediated cancer immunotherapy
Manman Xu, Hengwen Chen, Guanghui Zhu, et al.
Nano Today (2024) Vol. 56, pp. 102231-102231
Open Access | Times Cited: 9

Engineered extracellular vesicles enable high-efficient delivery of intracellular therapeutic proteins
Ding Ma, An Xie, Jiahui Lv, et al.
Protein & Cell (2024) Vol. 15, Iss. 10, pp. 724-743
Open Access | Times Cited: 8

Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy
Jia Tan, Meifang Wang, Binbin Ding, et al.
Coordination Chemistry Reviews (2023) Vol. 493, pp. 215316-215316
Closed Access | Times Cited: 17

In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors
Xiaoying Liu, Fangmin Chen, Madiha Saeed, et al.
Nano Today (2024) Vol. 56, pp. 102273-102273
Closed Access | Times Cited: 7

Harnessing enucleated cancer cells as Trojan horse cell vaccines
Wenli Fang, Zhangyan Jing, Yuan Li, et al.
Cell Reports Physical Science (2023) Vol. 5, Iss. 1, pp. 101752-101752
Open Access | Times Cited: 15

Novel emerging nano-assisted anti-cancer strategies based on the STING pathway
Xianghui Li, Haoran Wang, Yuanyuan Chen, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 13

Nanoformulations of chemotherapeutic activators of the cGAS–STING pathway in tumor chemoimmunotherapy
Lingzhi Wang, Zhuo Yu, Jihong Zhang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103892-103892
Closed Access | Times Cited: 5

Co-delivery of doxorubicin and STING agonist cGAMP for enhanced antitumor immunity
Yi Xie, Kangkang Li, Jinxin Liang, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123955-123955
Closed Access | Times Cited: 5

Hypoxia Reversion and STING Pathway Activation through Large Mesoporous Nanozyme for Near-Infrared-II Light Amplified Tumor Polymetallic-Immunotherapy
Chang Qu, Xinyue Shao, Ran Jia, et al.
ACS Nano (2024) Vol. 18, Iss. 33, pp. 22153-22171
Closed Access | Times Cited: 5

Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy
Lingzhi Wang, Shengnan Bi, Zhuo Li, et al.
Biomaterials (2024) Vol. 313, pp. 122766-122766
Closed Access | Times Cited: 5

Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma
Chenyu Cao, Yifei Li, Fangzhou Shi, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124424-124424
Closed Access | Times Cited: 4

Application of nanoparticles with activating STING pathway function in tumor synergistic therapy
Yi Yang, Yaning Fang, Xin‐Yu Du, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114013-114013
Closed Access

Nanodelivery of arsenic trioxide induces macrophage-governed cGAS-STING signaling to remodel immune microenvironment in hepatocellular carcinoma
Yuyao Li, Jia Shi, Shihan Yu, et al.
Chemical Engineering Journal (2025), pp. 159943-159943
Closed Access

Page 1 - Next Page

Scroll to top